BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38012557)

  • 1. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
    Javadi M; Sazegar H; Doosti A
    BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes.
    Azadbakht N; Doosti A; Jami MS
    Biol Proced Online; 2022 Jul; 24(1):8. PubMed ID: 35790898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Knockout Strategies to Ablate
    Zare K; Shademan M; Ghahramani Seno MM; Dehghani H
    Biol Proced Online; 2018; 20():21. PubMed ID: 30410426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
    Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
    Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.
    Jafari N; Kim H; Park R; Li L; Jang M; Morris AJ; Park J; Huang C
    PLoS One; 2017; 12(1):e0170327. PubMed ID: 28099519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Javadi M; Sazegar H; Doosti A
    Iran J Biotechnol; 2022 Oct; 20(4):e3115. PubMed ID: 38344320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
    Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
    Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing by CRISPR/Cas9 in Trypanosoma cruzi.
    Lander N; Chiurillo MA; Docampo R
    Methods Mol Biol; 2019; 1955():61-76. PubMed ID: 30868519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system.
    Hu W; Guo G; Chi Y; Li F
    J Cell Biochem; 2019 Sep; 120(9):14908-14915. PubMed ID: 31016787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
    Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
    Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time and Cost-Effective Genome Editing Protocol for Simultaneous Caspase 8 Associated Protein 2 Gene Knock in/out in Chinese Hamster Ovary Cells Using CRISPR-Cas9 System.
    Sorourian S; Behzad Behbahani A; Forouzanfar M; Jafarinia M; Safari F
    Iran J Biotechnol; 2024 Jan; 22(1):e3714. PubMed ID: 38827341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO
    Li J; Zhang L; Xu Q; Zhang W; Li Z; Chen L; Dong X
    Microbiol Spectr; 2022 Aug; 10(4):e0116522. PubMed ID: 35766512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity.
    Prior KK; Leisegang MS; Josipovic I; Löwe O; Shah AM; Weissmann N; Schröder K; Brandes RP
    Redox Biol; 2016 Oct; 9():287-295. PubMed ID: 27614387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.
    Li X; Sun B; Qian H; Ma J; Paolino M; Zhang Z
    J Zhejiang Univ Sci B; 2022 Feb; 23(2):141-152. PubMed ID: 35187887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells.
    Mandl M; Ritthammer H; Ejaz A; Wagner SA; Hatzmann FM; Baumgarten S; Viertler HP; Zwierzina ME; Mattesich M; Schiller V; Rauchenwald T; Ploner C; Waldegger P; Pierer G; Zwerschke W
    Adipocyte; 2020 Dec; 9(1):626-635. PubMed ID: 33070670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
    Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
    Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of IL17RB Knockout Cell Lines Using CRISPR/Cas9-Based Genome Editing.
    Hu O; Provvido A; Zhu Y
    Methods Mol Biol; 2020; 2108():345-353. PubMed ID: 31939193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
    Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
    Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.